Creating new imaging agents to improve surgery for pancreatic cancer
Official title: Development of contrast agents to facilitate image-guided surgery
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-10931584 · Data updated 2026-11-12
This study is working on new tools to help surgeons see pancreatic tumors more clearly during surgery, making it easier to remove them completely and improve outcomes for patients with pancreatic cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $563,640 |
| NIH project number | 5R01CA281098-02 |
| Project ID | NIH-10931584 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with pancreatic adenocarcinoma who are undergoing surgical resection.
✕Less likely to help
Patients with non-cancerous conditions or those who are not candidates for surgery may not benefit from this research.
What this research studies
This research focuses on developing advanced contrast agents that can help surgeons better identify pancreatic tumors during surgery. By using innovative imaging techniques, the study aims to enhance the visibility of tumors, particularly in challenging cases where traditional methods may fail. The approach involves investigating the use of specific biomarkers and imaging technologies to improve surgical outcomes for patients with pancreatic adenocarcinoma. The goal is to achieve more accurate tumor resections, minimizing the chances of leaving cancerous tissue behind.
Why it matters
Potential benefit: If successful, this research could lead to improved surgical outcomes and higher cure rates for patients with pancreatic cancer.
How similar studies have gone: Previous studies using fluorescent-guided surgery have shown promise, indicating that this approach could lead to significant advancements in surgical techniques for pancreatic cancer.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Mcnally, Lacey R — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Mcnally, Lacey R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.